Trial intelligence / Profile preview

Recovery of Oxytocin Responsiveness in Pregnant Human Myometrial Explants

NCT02762669Terminated

Sponsor
Mount Sinai Hospital
Start
Aug 2016
Primary completion
Dec 2023
Modality
Peptides
Countries
1
01

Overview

Trial of oxytocin in postpartum hemorrhage (PPH) (8 arms), sponsored by Mount Sinai Hospital. Primary endpoint: Oxytocin receptor (OTR) protein expression and localization at 24 hours. Started Aug 2016; status: terminated.

02

Drugs

oxytocin
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on NCT02762669.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02762669.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call